109 related articles for article (PubMed ID: 30274941)
1. A novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model.
Kunikawa S; Tanaka A; Takasuna Y; Tasaki M; Chida N
Bioorg Med Chem; 2018 Nov; 26(20):5499-5509. PubMed ID: 30274941
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions.
Kunikawa S; Tanaka A; Takasuna Y; Tasaki M; Chida N
Bioorg Med Chem; 2019 Mar; 27(5):790-799. PubMed ID: 30704835
[TBL] [Abstract][Full Text] [Related]
3. Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation.
Fukahori H; Chida N; Maeda M; Tasaki M; Kawashima T; Noto T; Tsujimoto S; Nakamura K; Oshima S; Hirose J; Higashi Y; Morokata T
Int Immunopharmacol; 2015 Aug; 27(2):232-7. PubMed ID: 26122135
[TBL] [Abstract][Full Text] [Related]
4. Optimization of 2,4-diamino-5-fluoropyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions and P-gp liability.
Kunikawa S; Tanaka A; Mukoyoshi K; Nagashima S; Tominaga H; Chida N; Tasaki M; Shirai F
Bioorg Med Chem; 2015 Jul; 23(13):3269-77. PubMed ID: 25982074
[TBL] [Abstract][Full Text] [Related]
5. Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005.
Papa P; Whitefield B; Mortensen DS; Cashion D; Huang D; Torres E; Parnes J; Sapienza J; Hansen J; Correa M; Delgado M; Harris R; Hegde S; Norris S; Bahmanyar S; Plantevin-Krenitsky V; Liu Z; Leftheris K; Kulkarni A; Bennett B; Hur EM; Ringheim G; Khambatta G; Chan H; Muir J; Blease K; Burnett K; LeBrun L; Morrison L; Celeridad M; Khattri R; Cathers BE
J Med Chem; 2021 Aug; 64(16):11886-11903. PubMed ID: 34355886
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of 4,6-diaminonicotinamide derivatives as novel and potent immunomodulators targeting JAK3.
Nakajima Y; Aoyama N; Takahashi F; Sasaki H; Hatanaka K; Moritomo A; Inami M; Ito M; Nakamura K; Nakamori F; Inoue T; Shirakami S
Bioorg Med Chem; 2016 Oct; 24(19):4711-4722. PubMed ID: 27544589
[TBL] [Abstract][Full Text] [Related]
7. Identification, Structure-Activity Relationships of Marine-Derived Indolocarbazoles, and a Dual PKCθ/δ Inhibitor with Potent Antipancreatic Cancer Efficacy.
Wang J; Jin W; Zhou X; Li J; Xu C; Ma Z; Wang J; Qin L; Zhou B; Ding W; Gao T; Yao H; Chen Z
J Med Chem; 2020 Nov; 63(21):12978-12991. PubMed ID: 33100009
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
9. AEB-071 versus tacrolimus monotherapy to prevent acute cardiac allograft rejection in the rat: a preliminary report.
Fang YH; Joo DJ; Lim BJ; Kim JY; Kim MS; Jeong HJ; Kim YS
Transplant Proc; 2010 Apr; 42(3):976-9. PubMed ID: 20430219
[TBL] [Abstract][Full Text] [Related]
10. AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts.
Nakamura K; Inami M; Morio H; Okuma K; Ito M; Noto T; Shirakami S; Hirose J; Morokata T
Eur J Pharmacol; 2017 Feb; 796():69-75. PubMed ID: 27993641
[TBL] [Abstract][Full Text] [Related]
11. Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunity.
May-Dracka TL; Arduini R; Bertolotti-Ciarlet A; Bhisetti G; Brickelmaier M; Cahir-McFarland E; Enyedy I; Fontenot JD; Hesson T; Little K; Lyssikatos J; Marcotte D; McKee T; Murugan P; Patterson T; Peng H; Rushe M; Silvian L; Spilker K; Wu P; Xin Z; Burkly LC
Bioorg Med Chem Lett; 2018 Jun; 28(10):1964-1971. PubMed ID: 29636220
[TBL] [Abstract][Full Text] [Related]
12. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
Deuse T; Hua X; Taylor V; Stubbendorff M; Baluom M; Chen Y; Park G; Velden J; Streichert T; Reichenspurner H; Robbins RC; Schrepfer S
Transplantation; 2012 Oct; 94(7):695-702. PubMed ID: 22971540
[TBL] [Abstract][Full Text] [Related]
13. B cells assist allograft rejection in the deficiency of protein kinase c-theta.
Yan W; Xu R; Ma LL; Han W; Geevarghese SK; Williams PE; Sciammas R; Chong AS; Yin DP
Transpl Int; 2013 Sep; 26(9):919-27. PubMed ID: 23841454
[TBL] [Abstract][Full Text] [Related]
14. Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection.
Burchat A; Borhani DW; Calderwood DJ; Hirst GC; Li B; Stachlewitz RF
Bioorg Med Chem Lett; 2006 Jan; 16(1):118-22. PubMed ID: 16216497
[TBL] [Abstract][Full Text] [Related]
15. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
Fang YH; Joo DJ; Lim BJ; Huh KH; Kim MS; Suh H; Kim YS
J Surg Res; 2011 Nov; 171(1):e133-7. PubMed ID: 21816421
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and optimization of furano[3,2-d]pyrimidines as selective spleen tyrosine kinase (Syk) inhibitors.
Hoemann M; Wilson N; Argiriadi M; Banach D; Burchat A; Calderwood D; Clapham B; Cox P; Duignan DB; Konopacki D; Somal G; Vasudevan A
Bioorg Med Chem Lett; 2016 Nov; 26(22):5562-5567. PubMed ID: 27789138
[TBL] [Abstract][Full Text] [Related]
17. Effect of AS2521780, a novel PKCθ selective inhibitor, on T cell-mediated immunity.
Fukahori H; Chida N; Maeda M; Tasaki M; Kawashima T; Matsuoka H; Suzuki K; Ishikawa T; Tanaka A; Higashi Y
Eur J Pharmacol; 2014 Dec; 745():217-22. PubMed ID: 25445039
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potent and selective PKC-theta inhibitors.
Cywin CL; Dahmann G; Prokopowicz AS; Young ER; Magolda RL; Cardozo MG; Cogan DA; Disalvo D; Ginn JD; Kashem MA; Wolak JP; Homon CA; Farrell TM; Grbic H; Hu H; Kaplita PV; Liu LH; Spero DM; Jeanfavre DD; O'Shea KM; White DM; Woska JR; Brown ML
Bioorg Med Chem Lett; 2007 Jan; 17(1):225-30. PubMed ID: 17055721
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model.
Koyanagi T; Noguchi K; Ootani A; Inagaki K; Robbins RC; Mochly-Rosen D
J Mol Cell Cardiol; 2007 Oct; 43(4):517-22. PubMed ID: 17655859
[TBL] [Abstract][Full Text] [Related]
20. CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders.
West K
Curr Opin Investig Drugs; 2009 May; 10(5):491-504. PubMed ID: 19431082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
